Showing results (61-70 of 88) with videos related to
Sort By:
Pageof 9
Clinical Nuclear Medicine|July 9, 2019
Integration of 68Ga-PSMA-PET/CT in Radiotherapy Planning for Prostate Cancer PatientsCem Onal, Nese Torun, Fadil Akyol, et al.Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|October 25, 2020
Half-dose bevacizumab experience in relapsed ovarian cancer patients in Turkey due to formal regulations: similar effectiveness with lower rate of hypertensionFatih Kose, Songul Alemdaroglu, Huseyin Mertsoylu, et al.Journal of Bone Oncology|March 1, 2019
Local control and vertebral compression fractures following stereotactic body radiotherapy for spine metastasesYurday Ozdemir, Nese Torun, Ozan Cem Guler, et al.Northern Clinics of Istanbul|September 29, 2021
Prognostic factors of endometrial cancer in elderly patient group and their effects on survivalSongul Alemdaroglu, Gulsen Dogan Durdag, Safak Yilmaz Baran, et al.Cancers|February 27, 2026
Prediction of Metastasis-Free Survival in Patients with Localized Prostate Adenocarcinoma Using Delta Radiomics from Pre-Treatment PSMA-PET/CT Scans and DosiomicsApurva Singh, William Silva Mendes, Sang-Bo Oh, et al.Radiation Medicine and Protection|March 19, 2026
A comparison of dimensionality reduction approaches for pre-treatment PSMA-PET/CT radiomics in prostate adenocarcinoma outcome predictionApurva Singh, William Silva Mendes, Sang-Bo Oh, et al.Acta Oncologica (Stockholm, Sweden)|May 17, 2021
Outcome and safety analysis of endometrial cancer patients treated with postoperative 3D-conformal radiotherapy or intensity modulated radiotherapyCem Onal, Sezin Yuce Sari, Guler Yavas, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 8, 2025
Prediction of metastasis-free survival in patients with localized prostate adenocarcinoma using primary tumor and lymph node radiomics from pre-treatment PSMA-PET/CT scansApurva Singh, William Silva Mendes, Sang-Bo Oh, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 31, 2020
Role of 68-Ga-PSMA-PET/CT in pelvic radiotherapy field definitions for lymph node coverage in prostate cancer patientsCem Onal, Gokhan Ozyigit, Ozan Cem Guler, et al.International Journal of Radiation Oncology, Biology, Physics|October 1, 2025
Gallium-68-Labeled Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography Response in Pelvic Node-Positive Prostate Cancer After Definitive Radiation Therapy: Prognostic ImplicationsCem Onal, Ozan Cem Guler, Nese Torun, et al.Pageof 9